Magnevist (Bayer HealthCare Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Magnevist drug offered from Bayer HealthCare Pharmaceuticals Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Bayer HealthCare Pharmaceuticals Inc. |
| NON-PROPRIETARY NAME: | Gadopentetate dimeglumine |
| SUBSTANCE NAME: | GADOPENTETATE DIMEGLUMINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2014-06-11 |
| END MARKETING DATE: | 0000-00-00 |
Magnevist HUMAN PRESCRIPTION DRUG Details:
| Item Description | Magnevist from Bayer HealthCare Pharmaceuticals Inc. |
| LABELER NAME: | Bayer HealthCare Pharmaceuticals Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 469.01(mg/mL) |
| START MARKETING DATE: | 2014-06-11 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 50419-188_130fbcc6-b111-43c2-81a6-9c961033878f |
| PRODUCT NDC: | 50419-188 |
| APPLICATION NUMBER: | NDA019596 |
Other GADOPENTETATE DIMEGLUMINE Pharmaceutical Manufacturers / Labelers:
